InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,319.31
(
2.30%
)
US TECH 100
17,985.60
(
0.35%
)
Dow Jones
39,446.49
(
1.76%
)
Brent Oil
78.67
(
-0.10%
)
Bitcoin
60,825.79
(
-1.47%
)

Replies to post #458173 on Anavex Life Sciences Corp (AVXL)

Replies to #458173 on Anavex Life Sciences Corp (AVXL)
icon url

mike_dotcom

05/02/24 4:05 PM

#458174 RE: georgejjl #458173

Please, somebody buy this POS company.
icon url

BIOChecker4

05/02/24 4:42 PM

#458179 RE: georgejjl #458173

You’ve been saying the same thing for at least 156 fort nights. If any of these companies were actually interested in partnering with or buying Anavex, they’d have done it by now.

Therefore, I am absolutely certain that Roche is not interested in partnering with or buying Anavex Life Sciences or licensing Blarcamesine from Anavex, nor do I believe that JNJ, Merck, Eli Lilly and Pfizer among other big Pharma are interested in Anavex Life Sciences.
icon url

sumbuysumsell

05/02/24 10:40 PM

#458205 RE: georgejjl #458173

I am absolutely certain that Roche is interested in partnering with or buying Anavex Life Sciences or licensing Blarcamesine from Anavex.


That's great news. Thank you for that. The price is $1,249 per share. And as part of the deal an allowance needs to be made for the dividend payments that would have also begun when AVXL had reached this share price.